Classic and novel roles of p53: prospects for anticancer therapy
José J. Fuster(Spanish National Centre for Cardiovascular Research), Vicente Andrés(Centro de Investigación en Red en Enfermedades Cardiovasculares), Ute M. Moll(Weatherford College), Silvia M. Sanz‐González(Instituto de Biomedicina de Valencia)
Cited by 126
Related Papers
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
|Science|2017|1.5k
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
|Journal of the American College of Cardiology|2018|673
Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease
|Circulation Research|2016|662
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
|Proceedings of the National Academy of Sciences|2007|598
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
|Proceedings of the National Academy of Sciences|1992|580